Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Drug Discov Today. 2018 Nov 16;24(2):616–623. doi: 10.1016/j.drudis.2018.11.005

Figure 3.

Figure 3.

Pharmacophore models of P-tau. 3D structural architecture of P-tau and the drug discovery workflow with 3D structure of target (tau), pharmacophores, pharmacophore models, virtual screening, ligand sets, molecular docking and best leads.